Barbara Walzog

Barbara Walzog is a Professor at the Biomedical Center Munich (BMC) within Ludwig Maximilian University of Munich. Her research focuses on molecular mechanisms of neutrophil activation and trafficking in inflammation, particularly through β2 integrin (CD11/CD18) and Syk kinase signaling pathways.

• Funding: TRR 332 - Neutrophils: origin, fate & function; SFB 914 - Trafficking of Immune Cells
• Contact: walzog@lrz.uni-muenchen.de

Her work integrates molecular, cellular, and in vivo approaches to study spatial-temporal dynamics of neutrophil activation in (patho-) physiological contexts. Recent publications highlight roles of midkine, coronin-1A, and myosin-1F in inflammatory processes including myocarditis, thrombosis, and wound healing. The group employs live-cell imaging and animal models to identify therapeutic targets.

Key collaborations include multiple cardiovascular immunology networks and the Sperandio group. Current research trends involve neutrophil-platelet interactions, integrin-mediated mechanotransduction, and metabolic regulation of inflammation.